MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 192 filers reported holding MYRIAD GENETICS INC in Q1 2020. The put-call ratio across all filers is 2.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $2,810,332 | +16.1% | 114,895 | +1.2% | 0.00% | 0.0% |
Q1 2024 | $2,420,033 | +16.8% | 113,510 | +4.8% | 0.00% | 0.0% |
Q4 2023 | $2,072,288 | +19.3% | 108,270 | 0.0% | 0.00% | 0.0% |
Q3 2023 | $1,736,651 | -30.8% | 108,270 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $2,509,699 | -0.2% | 108,270 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $2,515,112 | +44.2% | 108,270 | -9.9% | 0.00% | 0.0% |
Q4 2022 | $1,744,523 | -22.8% | 120,229 | +1.5% | 0.00% | 0.0% |
Q3 2022 | $2,259,000 | +1.7% | 118,399 | -3.1% | 0.00% | 0.0% |
Q2 2022 | $2,221,000 | -25.3% | 122,233 | +3.5% | 0.00% | 0.0% |
Q1 2022 | $2,975,000 | -8.5% | 118,071 | +0.3% | 0.00% | 0.0% |
Q4 2021 | $3,250,000 | -14.2% | 117,757 | +0.4% | 0.00% | 0.0% |
Q3 2021 | $3,789,000 | +2.2% | 117,330 | -3.2% | 0.00% | 0.0% |
Q2 2021 | $3,706,000 | +6.1% | 121,200 | +5.6% | 0.00% | -50.0% |
Q1 2021 | $3,494,000 | +56.3% | 114,730 | +1.5% | 0.00% | +100.0% |
Q4 2020 | $2,235,000 | +51.6% | 113,020 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $1,474,000 | +15.2% | 113,020 | +0.2% | 0.00% | 0.0% |
Q2 2020 | $1,280,000 | -25.3% | 112,850 | -5.8% | 0.00% | 0.0% |
Q1 2020 | $1,714,000 | -48.1% | 119,800 | -1.2% | 0.00% | -50.0% |
Q4 2019 | $3,302,000 | -34.5% | 121,260 | -31.1% | 0.00% | -33.3% |
Q3 2019 | $5,038,000 | -11.3% | 175,980 | -13.9% | 0.00% | -25.0% |
Q2 2019 | $5,679,000 | -2.0% | 204,420 | +17.1% | 0.00% | 0.0% |
Q1 2019 | $5,797,000 | +15.0% | 174,620 | +0.7% | 0.00% | 0.0% |
Q4 2018 | $5,041,000 | -39.0% | 173,420 | -3.5% | 0.00% | -20.0% |
Q3 2018 | $8,265,000 | +16.0% | 179,669 | -5.8% | 0.01% | 0.0% |
Q2 2018 | $7,126,000 | +44.2% | 190,678 | +14.0% | 0.01% | +25.0% |
Q1 2018 | $4,941,000 | -12.2% | 167,220 | +2.0% | 0.00% | 0.0% |
Q4 2017 | $5,630,000 | -5.1% | 163,930 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $5,931,000 | +42.1% | 163,930 | +1.5% | 0.00% | +33.3% |
Q2 2017 | $4,173,000 | +118.4% | 161,510 | +62.3% | 0.00% | +50.0% |
Q1 2017 | $1,911,000 | +7.5% | 99,510 | -6.7% | 0.00% | +100.0% |
Q4 2016 | $1,778,000 | -34.3% | 106,660 | -18.8% | 0.00% | -50.0% |
Q3 2016 | $2,705,000 | -36.8% | 131,414 | -6.1% | 0.00% | -50.0% |
Q2 2016 | $4,282,000 | -14.0% | 139,924 | +5.2% | 0.00% | 0.0% |
Q1 2016 | $4,979,000 | -5.2% | 133,029 | +9.3% | 0.00% | 0.0% |
Q4 2015 | $5,252,000 | +10.5% | 121,690 | -4.1% | 0.00% | 0.0% |
Q3 2015 | $4,755,000 | +10.1% | 126,860 | -0.1% | 0.00% | 0.0% |
Q2 2015 | $4,318,000 | +148.0% | 127,050 | +158.3% | 0.00% | +300.0% |
Q1 2015 | $1,741,000 | +2.3% | 49,184 | -1.6% | 0.00% | 0.0% |
Q4 2014 | $1,702,000 | -19.5% | 49,984 | -8.8% | 0.00% | -50.0% |
Q3 2014 | $2,113,000 | -0.3% | 54,784 | +0.6% | 0.00% | 0.0% |
Q2 2014 | $2,119,000 | +12.6% | 54,434 | -1.1% | 0.00% | 0.0% |
Q1 2014 | $1,882,000 | +75.2% | 55,031 | +7.5% | 0.00% | +100.0% |
Q4 2013 | $1,074,000 | -13.7% | 51,210 | -3.3% | 0.00% | 0.0% |
Q3 2013 | $1,244,000 | -11.6% | 52,940 | +1.1% | 0.00% | 0.0% |
Q2 2013 | $1,407,000 | – | 52,345 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 5,500,000 | $134,530 | 3.72% |
Glenview Capital Management | 3,748,432 | $91,686,647 | 1.80% |
ORACLE INVESTMENT MANAGEMENT INC | 60,000 | $1,467,600 | 1.37% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 240,128 | $5,873,531 | 1.10% |
DISCIPLINED GROWTH INVESTORS INC /MN | 2,087,328 | $51,056,043 | 0.96% |
OBERWEIS ASSET MANAGEMENT INC/ | 360,700 | $8,822,722 | 0.54% |
EARNEST PARTNERS LLC | 4,072,018 | $99,601,560 | 0.47% |
AIMZ Investment Advisors, LLC | 39,585 | $968,249 | 0.35% |
Eversept Partners, LP | 181,961 | $4,450,766 | 0.30% |
Hillsdale Investment Management Inc. | 151,180 | $3,697,863 | 0.29% |